Literature DB >> 14996595

Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease.

Pablo Avanzas1, Ramón Arroyo-Espliguero, Juan Cosin-Sales, Juan Quiles, Emmanouil Zouridakis, Juan Carlos Kaski.   

Abstract

We sought to assess the relation between circulating levels of inflammation markers, such as neopterin and C-reactive protein, and the development of adverse cardiovascular events in patients with hypertension but without obstructive coronary artery disease. We observed that patients who developed adverse events during follow-up had significantly higher neopterin levels compared with patients without events.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14996595     DOI： 10.1016/j.amjcard.2003.11.035

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  8 in total

1.  Modest correlation between serum neopterin levels and Gensini scores in a cohort of patients undergoing coronary angiography.

Authors:  C Özbek; I Baran; A Tütüncü; T Kuştarcı; K Karaağaç; A Özbek
Journal:  Ir J Med Sci       Date:  2013-08-29       Impact factor: 1.568

2.  Increased plasma neopterin levels are associated with reduced endothelial function and arterial elasticity in hypertension.

Authors:  Y-Y Zhang; X-Z Tong; W-H Xia; W-L Xie; B-B Yu; B Zhang; L Chen; J Tao
Journal:  J Hum Hypertens       Date:  2015-07-23       Impact factor: 3.012

Review 3.  Redox control of renal function and hypertension.

Authors:  Ravi Nistala; Adam Whaley-Connell; James R Sowers
Journal:  Antioxid Redox Signal       Date:  2008-12       Impact factor: 8.401

4.  The clinical and biochemical parameters in relation to the serum neopterin levels in Indian children and adolescents.

Authors:  Srinivasa Nageswara Rao G; Prema Gurumurthy; Sruti E; K M Cherian
Journal:  J Clin Diagn Res       Date:  2013-04-01

5.  Cellular immune activity biomarker neopterin is associated hyperlipidemia: results from a large population-based study.

Authors:  Shu-Chun Chuang; Heiner Boeing; Stein Emil Vollset; Øivind Midttun; Per Magne Ueland; Bas Bueno-de-Mesquita; Martin Lajous; Guy Fagherazzi; Marie-Christine Boutron-Ruault; Rudolf Kaaks; Tilman Küehn; Tobias Pischon; Dagmar Drogan; Anne Tjønneland; Kim Overvad; J Ramón Quirós; Antonio Agudo; Esther Molina-Montes; Miren Dorronsoro; José María Huerta; Aurelio Barricarte; Kay-Tee Khaw; Nicholas J Wareham; Ruth C Travis; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Giovanna Masala; Claudia Agnoli; Rosario Tumino; Amalia Mattiello; Petra H Peeters; Elisabete Weiderpass; Richard Palmqvist; Ingrid Ljuslinder; Marc Gunter; Yunxia Lu; Amanda J Cross; Elio Riboli; Paolo Vineis; Krasimira Aleksandrova
Journal:  Immun Ageing       Date:  2016-02-25       Impact factor: 6.400

6.  Salivary Stress-Related Responses in Tinnitus: A Preliminary Study in Young Male Subjects with Tinnitus.

Authors:  Ola A Alsalman; Denise Tucker; Sven Vanneste
Journal:  Front Neurosci       Date:  2016-07-20       Impact factor: 4.677

7.  Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes.

Authors:  Edward C A Marks; Tom M Wilkinson; Chris M Frampton; Lorraine Skelton; Anna P Pilbrow; Tim G Yandle; Chris J Pemberton; Robert N Doughty; Gillian A Whalley; Chris J Ellis; Richard W Troughton; Maurice C Owen; Neil R Pattinson; Vicky A Cameron; A Mark Richards; Steven P Gieseg; Barry R Palmer
Journal:  BMC Cardiovasc Disord       Date:  2018-08-15       Impact factor: 2.298

Review 8.  Role of neopterin as an inflammatory biomarker in congestive heart failure with insights on effect of drug therapies on its level.

Authors:  Gaidaa M Dogheim; Mohamed T Amralla; Rehab H Werida
Journal:  Inflammopharmacology       Date:  2022-07-25       Impact factor: 5.093
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.